-
3D Cardiac Organoid Mapping with Shell MEAs
2026-08-13
The reference study introduces shape-adaptive shell microelectrode arrays that wrap cardiac organoids and record electrical activity across three dimensions. By combining customizable electrode layouts, conduction mapping, calcium imaging, and pharmacological challenges including E-4031, the platform expands cardiac electrophysiology research beyond the planar limits of conventional MEAs.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-08-12
Build reproducible translation, delivery, viability, and imaging assays around a Cap1- and poly(A)-optimized firefly luciferase transcript. The workflow also shows how the reference study’s adaptive nanocoacervates could be evaluated as a cytosolic delivery strategy without confusing uptake with productive protein expression.
-
RISOTTO Trial: Risedronate for RA-Related GIO
2026-08-12
The RISOTTO study addressed an important evidence gap by testing sodium risedronate in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis in a multicentre randomized trial. Risedronate produced a significant six-month increase in lumbar spine bone mineral density and was well tolerated, although effects at the hip and fracture outcomes require further study.
-
SETD7 Depletion Promotes Adipose Browning in Obesity
2026-08-11
This study identifies the lysine methyltransferase SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis. In obese mice, genetic Setd7 reduction enhanced beige-fat activation through an Adcy7–Sirt1–Creb1 signaling axis, increased energy expenditure, and improved resistance to high-fat-diet-induced metabolic dysfunction.
-
Sodium Nitroprusside in Sex-Difference Vascular Assays
2026-08-11
Sodium Nitroprusside provides a practical nitric oxide donor challenge for separating vascular smooth muscle responsiveness from upstream hypertension mechanisms. This guide translates sex-specific angiotensin II findings into reproducible tissue, platelet, and integrated assay workflows, with actionable preparation and troubleshooting advice.
-
MHI148 Photodynamic Therapy and STING Activation
2026-08-10
The reference study developed GM@P nanoparticles that combine MHI148-mediated photodynamic therapy with 2′3′-cGAMP activation of STING to address tumor recurrence and metastasis. Its findings support a coordinated strategy in which immunogenic cell death, type I interferon induction, dendritic-cell maturation, and CD8+ T-cell infiltration reinforce one another.
-
Metoprolol Workflows for Cardiovascular Research
2026-08-09
Build reproducible beta1-receptor perturbation assays with Metoprolol, from fresh-solution handling and concentration screening to mechanistic validation. The workflow also shows how pharmacokinetic study design can strengthen cardiovascular, inflammatory, cancer, and angiogenesis experiments without overinterpreting cross-domain evidence.
-
BMAL1 Phase Separation and Circadian Transcription
2026-08-08
Gao et al. identify BMAL1 as a phase-separating clock factor that forms dynamic nuclear condensates and transcriptional hubs. Their experiments connect an N-terminal intrinsically disordered region and its phosphorylation state to the recruitment of transcriptional machinery, rhythmic gene expression, and circadian behavior.
-
Pazopanib Hydrochloride In Vitro Workflows
2026-08-07
Build more informative cancer assays with Pazopanib Hydrochloride by separating growth inhibition from true cell killing. This guide combines multi-kinase pathway testing, angiogenesis models, time-resolved viability measurements, and practical troubleshooting for renal cell carcinoma and soft tissue sarcoma research.
-
Bestatin Hydrochloride: Molecular Precision in Angiogenesis
2026-08-07
Explore the multifaceted scientific applications of Bestatin hydrochloride (Ubenimex) as a precision tool for dissecting angiogenesis and tumor biology. This article reveals unique mechanistic insights and practical protocol guidance not covered by standard workflow or neuroendocrine studies.
-
Technical Workflow Guide: Angiotensin I/II (1-5) in RAS Rese
2026-08-06
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for reproducible modeling of blood pressure regulation and aldosterone signaling in renin-angiotensin system (RAS) studies. It is suitable for cardiovascular and renal research workflows but is not recommended for unrelated peptide signaling or off-target mechanistic assays due to its specific solubility and mechanistic profile.
-
Nuclear-Targeted Peptide Nanorods and DMXAA for Innate Tumor
2026-08-06
This study introduces nuclear-targeted chimeric peptide nanorods (PFPD) as a platform for amplifying innate anti-tumor immunity through localized DNA damage and synergistic STING activation. By integrating photodynamic DNA disruption and a STING agonist (DMXAA), the research demonstrates significant enhancement of NK and T cell responses, highlighting a promising strategy for systemic tumor immunotherapy.
-
Brinzolamide Nanoemulsions: Safety and Permeation Insights i
2026-08-05
This study systematically evaluates brinzolamide-loaded nanoemulsions for ocular drug delivery, demonstrating enhanced corneal permeability and robust safety profiles through ex vivo and in vitro assays. Notably, Triacetin was identified as a minimally cytotoxic excipient, supporting its continued use and investigation in ophthalmic formulations.
-
ICAA Attenuates Cardiac Hypertrophy via RIP3/CaMKII Pathway
2026-08-05
This study identifies isochlorogenic acid A (ICAA) as a novel regulator of angiotensin II-induced cardiac hypertrophy, acting by directly inhibiting RIP3 phosphorylation and the downstream CaMKII signaling cascade. These findings reveal the RIP3/CaMKII axis as a potential therapeutic target for cardiovascular disease, offering new strategies for mechanistic research in cardiac remodeling.
-
Bradykinin (BA5201): Technical Guide for Vasodilator Assays
2026-08-04
Bradykinin (BA5201) is a validated endothelium-dependent vasodilator peptide used for studies on vascular permeability, smooth muscle contraction, and inflammation signaling pathways. This product provides researchers with a consistent reagent for cardiovascular and pain mechanism research but is not suitable for diagnostic or therapeutic applications.